News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Military champion has Prytime Medical ready for prime time

Prytime Medical Devices Inc. CEO David Spencer said his company is poised to take its flagship technology ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
Spanish Oncologists Tour San Antonio's START Center
November 20, 2012

By Berit Mason, 1200 WOAI News Radio

Sometimes it's helpful to learn how the other guy does it ... which is why some cancer doctors from Spain were visiting local oncologists at San Antonio's START Center.

"Over the last little while we have trained and continue to train people from China, from Spain and most recently from Japan," says START's Anthony Tolcher M.D.

Tolcher says the Spaniards learned about administering Phase 1 clinical trials to patients ... testing new drugs to cure cancer.

"But the type of work that we do is taking these drugs into patients for the first time; right out of the laboratory and into the patient." Something the Spanish also want to do."

He says cancer doctors from the world over come to START.

"There are very few physicians in the world that do the kind of work that we do here at START, where new compounds come out of the laboratory and go into patients for the first time," says Tolcher.

He says the Spanish doctors will bring what they have learned back to the University of Navarra in Pamplona, one of Europe's premiere medical institutions.

START has the largest Phase One Medical Oncology Program, with locations in Madrid and Shanghai as well as in San Antonio, so promising new drugs can be tested around the world and around the clock. Its mission is to accelerate the development of new cancer drugs with the purpose of improving quality of life and survival for patients with cancer.

 

Stay informed. Subscribe to BioMed SA news alerts.